MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species

Microphthalmia-associated transcription factor (MITF) is a master regulator of melanocyte function, development and plays a significant role in melanoma pathogenesis. MITF genomic amplification promotes melanoma development, and it can facilitate resistance to multiple therapies. Here, we show that MITF regulates a global antioxidant program that increases survival of melanoma cell lines by protecting the cells from reactive oxygen species (ROS)-induced damage. In addition, this redox program is correlated with MITF expression in human melanoma cell lines and patient-derived melanoma samples. Using a zebrafish melanoma model, we show that MITF decreases ROS-mediated DNA damage in vivo. Some of the MITF target genes involved, such as IDH1 and NNT, are regulated through direct MITF binding to canonical enhancer box (E-BOX) sequences proximal to their promoters. Utilizing functional experiments, we demonstrate the role of MITF and its target genes in reducing cytosolic and mitochondrial ROS. Collectively, our data identify MITF as a significant driver of the cellular antioxidant state.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2024-09-14
DOI
https://doi.org/10.1038/s41598-024-72031-9
Citations
10
Primary Topic
melanin and skin pigmentation
Type
article
Field-Weighted Citation Impact
3.26

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species

Anna Lengyel, Poguang Wang, Alicia M. McConnell, Vivien Igras et al.
10 citations
Scientific Reports
melanin and skin pigmentation
3.26
article

MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species

Anna Lengyel, Poguang Wang, Alicia M. McConnell, Vivien Igras, Yusuke Suita, Thomas G. Graeber, Arimichi Okazaki, Othon Iliopoulos, Roger W. Giese, Alexander A. Navarini, Rebecca Lapides, D. Pal, Alina Mueller, Anna A. Ascsillán, Elisabeth Roider, Akinori Kawakami, David E. Fisher, Leonard Ira Zon, Botond L. Szabolcs, Jennifer Tsoi, Jennifer J. Hsiao, Lajos V Kemeny, I Németh, Jennifer A. Lo, Alexandra I.T. Lakatos
article en
10 citations

Abstract

Microphthalmia-associated transcription factor (MITF) is a master regulator of melanocyte function, development and plays a significant role in melanoma pathogenesis. MITF genomic amplification promotes melanoma development, and it can facilitate resistance to multiple therapies. Here, we show that MITF regulates a global antioxidant program that increases survival of melanoma cell lines by protecting the cells from reactive oxygen species (ROS)-induced damage. In addition, this redox program is correlated with MITF expression in human melanoma cell lines and patient-derived melanoma samples. Using a zebrafish melanoma model, we show that MITF decreases ROS-mediated DNA damage in vivo. Some of the MITF target genes involved, such as IDH1 and NNT, are regulated through direct MITF binding to canonical enhancer box (E-BOX) sequences proximal to their promoters. Utilizing functional experiments, we demonstrate the role of MITF and its target genes in reducing cytosolic and mitochondrial ROS. Collectively, our data identify MITF as a significant driver of the cellular antioxidant state.

Scientific ReportsVol. 14(1)
Semmelweis University (HU), University of Vermont (US), Northeastern University (US), Howard Hughes Medical Institute (US), Harvard University (US), University of California, Los Angeles (US), University of Szeged (HU), University Hospital of Basel (CH), Massachusetts General Hospital (US), Dana-Farber Cancer Institute (US), Dana-Farber/Harvard Cancer Center (US), Center for Cancer Research (US), Eastern University (BD), Institute for Molecular Medicine (US)
Melanoma Research Alliance, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, Harvard University, Harvard Catalyst, Semmelweis Egyetem, Hungarian Scientific Research Fund, Magyar Tudományos Akadémia, Universität Zürich, National Institutes of Health, National Research, Development and Innovation Office, National Center for Advancing Translational Sciences
Openalex Percentile: Top 8%
melanin and skin pigmentation
3.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.